本文へ移動
cccskills
無料GitHub で公開

es-assess-gd-dsm5-criteria

This skill determines whether an adolescent or adult patient meets DSM-5 criteria for gender dysphoria (gender incongruence) by evaluating the presence of at least two of six specified criteria over a minimum 6-month duration, accompanied by clinically significant distress or impairment. It is triggered when a clinician queries whether the patient's reported symptoms align with gender dysphoria, such as persistent incongruence between experienced/expressed gender and designated gender.

dromlakhani/MD2SKILL
インストール方法を見る

含まれるファイル（1）

  • SKILL.md3.4 KB

SKILL.md（原文）

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Assess for gender dysphoria using DSM-5 criteria

STEP 1 — Gather Information

Collect patient's self-reported experiences regarding gender identity, duration of incongruence, and specific manifestations: (1) incongruence between experienced/expressed gender and primary/secondary sex characteristics (or anticipated characteristics in young adolescents), (2) strong desire to be rid of primary/secondary sex characteristics, (3) strong desire for primary/secondary sex characteristics of the other gender, (4) strong desire to be of the other gender, (5) strong desire to be treated as the other gender, (6) strong conviction of having typical feelings/reactions of the other gender. Assess for clinically significant distress or impairment in social, occupational, or other important areas of functioning.

STEP 2 — Rule In / Rule Out

Is there a marked incongruence between experienced/expressed gender and natal gender lasting at least 6 months? If no, rule out gender dysphoria. If yes, proceed to evaluate specific criteria and distress/impairment.

STEP 3 — Classify or Stratify

Count how many of the six DSM-5 criteria (items 1–6) are met. If at least two criteria are present AND clinically significant distress/impairment is documented, the patient meets DSM-5 criteria for gender dysphoria. Specify if concurrent with a disorder of sex development or if posttransitional (full-time living in desired gender with at least one sex-related medical procedure).

STEP 4 — Decide

If criteria are met, refer to a qualified mental health provider for formal diagnosis and discuss potential gender-affirming treatment pathways per endocrine guideline. If criteria are not met, explore alternative explanations for distress (e.g., body dysmorphic disorder, depression, anxiety) and consider further psychosocial assessment.

Clinical Guardrails / Mimics / Pitfalls

Do not diagnose gender dysphoria based solely on gender-nonconforming behavior without distress/impairment; avoid conflating with body dysmorphic disorder or other mental health conditions; ensure symptom duration is at least 6 months; consider developmental appropriateness in adolescents (e.g., anticipated secondary sex characteristics); verify that distress is not better explained by another psychiatric disorder or medical condition.

Concrete Clinical Example

A 17-year-old assigned female at birth reports a 10-month history of strong desire to be rid of breasts and menstruation, strong desire to have male-typical chest contour, and persistent distress when misgendered, leading to social withdrawal and declining grades. They meet criteria 2 and 3 with clinically significant impairment, supporting a DSM-5 gender dysphoria diagnosis.

Source: Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2017, DOI:10.1210/jc.2017-01658

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

ログインしてレビューを書く

同じリポジトリのスキル

概要と使いどころ

780g-pump-adjustment

無料

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-acth-stim-test-interpretation

無料

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-adrenal-crisis-treatment

無料

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-ai-education

無料

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-lt4-monitoring

無料

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-cortisol-cutoff-ai-diagnosis

無料

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する